Survivin as a potential biomarker for early diagnosis of the progression of precancerous lesions to gastric cancer.
Amirreza Mahmoudzadeh-SaghebMehran PanahiSetareh JamiBita MoudiHamidreza Mahmoudzadeh-SaghebZahra HeidariPublished in: The International journal of biological markers (2023)
It seems that the steady increase in survivin expression from different precancerous lesions to gastric adenocarcinoma suggests that survivin can be used as a potential biomarker for the prevention and early diagnosis of gastric cancer.